Moving averages of IBB’s holdings
The iShares Nasdaq Biotechnology ETF (IBB) holds 189 stocks in its portfolio. On May 27, 2016, 17% of IBB’s stocks were trading above their 20-day moving averages, 35% were trading above their 50-day moving averages, and 41% were trading above their 100-day moving averages.
The above graph shows the percentage of IBB’s holdings trading at different moving averages on May 27, 2016. Out of IBB’s 189 stocks, 33 were trading above their 20-day moving averages, 67 were trading above their 50-day moving averages, and 78 were trading above their 100-day moving averages.
What is IBB’s moving average trend?
On May 27, 2016, IBB closed at $276.19, and it was trading above its 20-day, 50-day, and 100-day moving averages.
On May 2, 2016, IBB’s 20-day moving average was $279.2, and on May 27, 2016, IBB’s 20-day moving average was $263.3, indicating a downward trend.
Few IBB stocks are trading above the 20-day moving average
Qiagen (QGEN), Myriad Genetics (MYGN), Sage Therapeutics (SAGE), and Pacira Pharmaceuticals (PCRX) are some of the 33 of IBB’s stocks that are trading above their 20-day moving averages. All four stocks have shown downward trends in their 20-day moving average prices since May 2, 2016.
Moving averages help investors to identify price trends and compare stocks’ current prices with different moving average prices. This helps investors to identify support and resistance levels and to make informed investment decisions.